PCM
JAZZ icon

Polaris Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Polaris Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$79.3M Sell
328,966
-86,400
-21% -$18.9M 7.47% 2
2026
Q1 		$78.5M Sell
415,366
-17,100
-4% -$2.99M 6.42% 2
2025
Q4 		$73.5M Sell
432,466
-81,000
-16% -$12.4M 6.1% 2
2025
Q3 		$67.7M Sell
513,466
-120,694
-19% -$14.5M 4.45% 5
2025
Q2 		$67.3M Sell
634,160
-245,000
-28% -$26.6M 4.48% 5
2025
Q1 		$109M Sell
879,160
-206,700
-19% -$27M 6.24% 5
2024
Q4 		$134M Sell
1,085,860
-219,700
-17% -$25.9M 6.45% 4
2024
Q3 		$145M Sell
1,305,560
-69,900
-5% -$7.66M 7.17% 3
2024
Q2 		$147M Sell
1,375,460
-57,200
-4% -$6.29M 7.87% 3
2024
Q1 		$173M Buy
1,432,660
+165,200
+13% +$20.2M 8.6% 3
2023
Q4 		$156M Buy
1,267,460
+27,100
+2% +$3.38M 7.53% 3
2023
Q3 		$161M Sell
1,240,360
-56,300
-4% -$7.5M 8.65% 2
2023
Q2 		$161M Sell
1,296,660
-11,200
-0.9% -$1.51M 6.04% 2
2023
Q1 		$191M Buy
1,307,860
+54,500
+4% +$8.06M 7.14% 2
2022
Q4 		$200M Sell
1,253,360
-217,100
-15% -$31.8M 6.95% 2
2022
Q3 		$196M Sell
1,470,460
-7,800
-0.5% -$1.19M 7.69% 2
2022
Q2 		$231M Sell
1,478,260
-25,700
-2% -$3.96M 8.24% 2
2022
Q1 		$234M Sell
1,503,960
-8,500
-0.6% -$1.23M 7.44% 2
2021
Q4 		$193M Sell
1,512,460
-450,303
-23% -$59.2M 6.21% 4
2021
Q3 		$256M Buy
1,962,763
+670,003
+52% +$101M 8.15% 2
2021
Q2 		$230M Buy
+1,292,760
New +$224M 7.41% 2

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Polaris Capital Management's JAZZ Position: Q2 2026 in Review

Polaris Capital Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 21% in Q2 2026, selling an estimated $18.9M and leaving 328,966 shares worth $79.3M. The position accounts for 7.47% of the portfolio, ranked #2.

Polaris Capital Management first reported a position in JAZZ in Q2 2021 and has held it in 21 quarters since. The position peaked at $256M in Q3 2021. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Polaris Capital Management held 328,966 shares of Jazz Pharmaceuticals worth $79.3M as of Q2 2026.
  • Polaris Capital Management sold 86,400 Jazz Pharmaceuticals shares in Q2 2026, an estimated $18.9M.
  • Jazz Pharmaceuticals made up 7.47% of Polaris Capital Management's portfolio in Q2 2026, its #2 holding.
  • Polaris Capital Management first reported a position in Jazz Pharmaceuticals in Q2 2021 and has held it in 21 quarters since.
  • Polaris Capital Management's Jazz Pharmaceuticals position peaked at $256M in Q3 2021.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Polaris Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.